EQS-News
105
0 Kommentare
DEFENCE THERAPEUTICS SIGNS WITH GERMAN BASED FMS CONSULT GMBH FOR FINANCING STRATEGY TO SUPPORT DEFENCE PIPELINE GROWTH - Seite 2
105 
0 Kommentare
Neither the CSE nor its market regulator, as that term is defined in the policies of the CSE, accepts responsibility for the adequacy or accuracy of this release.
17.04.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
| Language: | English |
| Company: | Defence Therapeutics Inc. |
| 1680 - 200 Burrard St | |
| V6C3L6 Vancouver | |
| Canada | |
| E-mail: | info@defencetherapeutics.com |
| Internet: | https://defencetherapeutics.com |
| ISIN: | CA24463V1013 |
| WKN: | A3CN14 |
| Listed: | Regulated Unofficial Market in Frankfurt, Stuttgart; Toronto |
| EQS News ID: | 1882095 |
| End of News | EQS News Service |
|
|
Lesen Sie auch
1882095 17.04.2024 CET/CEST
Diskutieren Sie über die enthaltenen Werte
Aktuelle Themen
Weitere Artikel des Autors
Verfasst von EQS Group AG
URL kopieren
Per E-Mail teilen
Artikel drucken1 im Artikel enthaltener WertIm Artikel enthaltene Werte
Artikel zu den Werten
Auch bei Lesern beliebt
